Latest Breaking News On - Sarepta therapeutics daily - Page 8 : comparemela.com

MBB Public Markets I LLC Cuts Stock Holdings in Sarepta Therapeutics, Inc (NASDAQ:SRPT)

MBB Public Markets I LLC decreased its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 4.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,000 shares of the biotechnology company’s stock after selling 200 shares during the […]

Needham companyA davidsonJpmorgan chase coExchange commissionSarepta therapeutics company profileAcadian asset managementRoyal bankNeuberger berman groupCantor fitzgeraldMbb public marketsCapital managementPublic marketsSarepta therapeutics incSarepta therapeuticsFree reportAsset management

Sarepta Therapeutics (SRPT) Scheduled to Post Earnings on Wednesday

Sarepta Therapeutics (SRPT) Scheduled to Post Earnings on Wednesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandVanguard group incGeode capital managementPricet rowe associates incSarepta therapeutics incWellington management groupJpmorgan chase coNeedham companySarepta therapeuticsGet free reportManagement groupStreet corpCapital managementPricet rowe associatesSarepta therapeutics daily

Sarepta Therapeutics (SRPT) Scheduled to Post Earnings on Wednesday

Sarepta Therapeutics (SRPT) Scheduled to Post Earnings on Wednesday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandRoyal bankDeutsche bank aktiengesellschaftVanguard group incGeode capital managementPricet rowe associates incSarepta therapeutics incWellington management groupSarepta therapeuticsGet free reportBank aktiengesellschaftManagement groupStreet corpCapital managementPricet rowe associates

Sarepta Therapeutics (NASDAQ:SRPT) Price Target Raised to $138 00 at Evercore ISI

Sarepta Therapeutics (NASDAQ:SRPT) Price Target Raised to $138 00 at Evercore ISI
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandMorgan stanleySarepta therapeutics incSarepta therapeutics company profileRoyal bankBlackrock incDeutsche bank aktiengesellschaftVanguard group incCapital international investorsAvoro capital advisorsWellington management groupSarepta therapeuticsGet free reportInternational investorsCapital advisors

Sarepta Therapeutics (NASDAQ:SRPT) Price Target Raised to $138 00 at Evercore ISI

Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its target price hoisted by investment analysts at Evercore ISI from $108.00 to $138.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has an “in-line” rating on the biotechnology company’s stock. Evercore ISI’s price objective would indicate a potential upside of 2.32% from the […]

New zealand generalNew zealandMorgan stanleyVanguard group incDeutsche bank aktiengesellschaftBlackrock incRoyal bankSarepta therapeutics company profileSarepta therapeutics incCapital international investorsWellington management groupAvoro capital advisorsSarepta therapeuticsGet free reportInternational investorsCapital advisors